Amedisys ($AMED) announced that it has agreed in principle to settle a securities class action lawsuit, Bach, et al. v. Amedisys, Inc., et al., Case No. 3:10-cv-00395. The case is pending in a Louisiana court since mid-2010. Amedisys has agreed to pay $43.75 million to settle the litigation, of which $15 million will be paid by its insurance carrier. The settlement is payable in the third quarter this year.
Argos Therapeutics ($ARGS) announced that it has inked a new deal with the investor Pharmstandard International S.A. for the direct sale of a $6 million secured convertible promissory note. The companies expect the deal to be closed by June 21. At Pharmstandard's discretion, the notes may be converted into shares of Argos common stock at $0.50 per share at any time.